厦门象屿股份有限公司2025年度持续督导年度报告——投资者详细解读
报告核心要点梳理
- 厦门象屿股份有限公司于2025年2月完成向特定对象发行A股，共计573,932,226股，发行价格为5.61元/股，募集资金总额为32.20亿元，扣除发行费用后，募集资金净额为31.79亿元。
- 中国国际金融股份有限公司（中金公司）担任本次发行的保荐机构，并负责2025年2月27日至2026年12月31日的持续督导工作，本报告涵盖2025年2月27日至2025年12月31日。
- 保荐机构已建立健全持续督导制度，并与公司签署了持续督导协议，对公司治理、内控制度、信息披露等多方面进行了全面监督和现场检查。
- 截至本报告期内，厦门象屿及其控股股东、实际控制人、董事、高管不存在违法违规、违背承诺、重大财务造假、资金占用、违规担保或其他重大异常事项。
- 公司募集资金的使用与募集说明书保持一致，未发现资金被挪用、项目未按承诺推进等情况，保荐机构已出具专项核查意见。
- 信息披露方面，保荐机构对公司所有披露文件进行了事前或及时审阅，未发现虚假记载、误导性陈述或重大遗漏。
- 本报告期间，厦门象屿未出现应向监管机构报告的其他重大事项。
对投资者和股东的特别提示
- 募集资金安全： 募集资金管理规范，未发现违规使用或挪用，投资者可对公司财务安全性保持信心。
- 公司治理与合规： 公司治理结构健全，内控制度完善，董事及高管履职情况良好，未出现重大合规风险。
- 信息披露透明： 所有重大信息均依法及时披露，未出现虚假或误导性陈述，信息披露合规、透明。
- 无负面事件： 公司、控股股东及高管未涉及重大违法违规、资金占用、违规担保、财务造假等情形，对公司经营稳定性具备正面影响。
- 行业监管合规： 公司及相关当事人未因违反证券相关规定而受到证监会或交易所处罚，无因未履行承诺而受监管措施的情况。
- 股价影响因素： 报告未披露任何负面或重大变动事件，预计对公司短期股价不会构成重大利空或利好影响。
投资者需关注的潜在风险或机会
- 当前公司经营、治理与资金管理均处于健康稳定状态，未见重大风险暴露。
- 如未来出现资金使用异常、重大财务造假、控股股东违规资金占用等事项，将对公司股价和投资者信心产生重大负面影响，投资者需持续关注公司后续信息披露。
- 本次持续督导报告显示公司治理能力与合规水平较高，有助于提升市场认可度和估值水平。
结论
本次持续督导年度报告显示，厦门象屿股份有限公司在2025年度募集资金管理、公司治理、信息披露等方面均表现合规、稳健，未出现对公司股价产生重大不利影响的事件。公司治理与内控持续完善，信息披露透明，资金使用规范，经营风险可控。投资者可继续关注公司后续业务发展及信息披露动态。
免责声明：本文内容基于厦门象屿股份有限公司2025年度持续督导年度报告书，仅供投资者参考，不构成任何投资建议。投资者应结合自身风险偏好和实际情况谨慎决策。
ENGLISH VERSION
Xiamen Xiangyu Co., Ltd. 2025 Annual Continuous Supervision Report – Detailed Investor Interpretation
Key Highlights of the Report
- In February 2025, Xiamen Xiangyu issued 573,932,226 A-shares to specific investors at 5.61 RMB/share, raising a total of RMB 3.22 billion. After deducting issuance costs, the net proceeds were RMB 3.18 billion.
- China International Capital Corporation (CICC) acts as the sponsor for this issuance and is responsible for the continuous supervision from February 27, 2025, to December 31, 2026. This report covers the period from February 27, 2025, to December 31, 2025.
- The sponsor has established a sound supervision system, signed a supervision agreement with the company, and conducted comprehensive oversight and onsite inspections on governance, internal controls, and information disclosure.
- During the reporting period, neither Xiamen Xiangyu nor its controlling shareholders, actual controllers, directors, or senior management had any violations, breaches of commitment, major financial fraud, fund misappropriation, illegal guarantees, or other significant abnormalities.
- The use of raised funds was consistent with the offering prospectus; no evidence was found of misappropriation or project delays. The sponsor has issued a special verification opinion.
- All information disclosures were reviewed by the sponsor in advance or promptly afterwards. No false records, misleading statements, or major omissions were found.
- During the reporting period, there were no other major events requiring reporting to regulators.
Special Reminders for Investors and Shareholders
- Safety of Raised Funds: The management of funds is compliant and no irregularities or misappropriation were found, giving investors confidence in the company’s financial security.
- Corporate Governance and Compliance: Governance structure is sound, internal controls are robust, and directors and executives have fulfilled their duties well, with no major compliance risks.
- Transparent Information Disclosure: All major information was disclosed in accordance with laws and regulations, with no false or misleading statements. Disclosure is timely and transparent.
- No Negative Events: The company, its controlling shareholders, and management have not been involved in major violations, fund misappropriation, illegal guarantees, or financial fraud, which is positive for operational stability.
- Regulatory Compliance: The company and related parties have not been penalized by the CSRC or the stock exchange for violations of securities regulations, nor have they failed to fulfill commitments.
- Share Price Impact: The report does not disclose any negative or material changes. No significant positive or negative impact is expected on the stock price in the short term.
Risks or Opportunities Investors Should Note
- The company’s operations, governance, and fund management are currently healthy and stable, with no major risks exposed.
- If there are future abnormalities in fund usage, major financial fraud, or fund occupation by controlling shareholders, this could significantly negatively impact the company’s stock price and investor confidence. Investors should monitor subsequent disclosures.
- The report demonstrates high governance and compliance standards, which may enhance market recognition and valuation.
Conclusion
The 2025 annual continuous supervision report shows Xiamen Xiangyu’s fundraising management, governance, and information disclosure are all compliant and stable, with no events likely to negatively impact the stock price. The company continues to improve its governance and internal controls, maintains transparent disclosure, and uses funds properly. Investors should continue to monitor the company’s ongoing business development and information disclosures.
Disclaimer: This article is based on Xiamen Xiangyu Co., Ltd.’s 2025 annual continuous supervision report and is for investor reference only. It does not constitute investment advice. Investors should make decisions cautiously according to their own risk preferences and actual circumstances.
